Company intelligence / Profile preview

Kaleidoscope Bio

California, United Stateskaleidoscope.bio ↗

Ownership: Private
Development stage: Other

Overview

Kaleidoscope Bio provides an integrated software platform designed to streamline and accelerate R&D operations for biotech and life sciences companies. The platform enables teams to track data, manage projects, make data-driven decisions, collaborate efficiently with internal and external partners (such as CROs), and maintain auditable records. It aims to reduce time-to-clinic by over a year per program, cut operating costs by over $1M per year in FTEs, improve decision accuracy with versioned data trails, and facilitate efficient communication of progress to stakeholders.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Collaborates with biotech companies using its platform for R&D management

Beyond the preview

Go deeper on Kaleidoscope Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaleidoscope Bio.

Explore the full profile